Delphia (Usa) Inc. Ionis Pharmaceuticals Inc Transaction History

Delphia (Usa) Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$33.58 - $41.2 $143,923 - $176,583	-4,286 Reduced 36.91%	7,326 $261,000
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $74,796 - $93,737	2,015 Added 21.0%	11,612 $438,000
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $10,450 - $13,916	286 Added 3.07%	9,597 $424,000
Q2 2022 Aug 15, 2022	BUY	$31.71 - $43.0 $98,142 - $133,085	3,095 Added 49.79%	9,311 $345,000
Q1 2022 May 16, 2022	BUY	$29.88 - $37.04 $185,734 - $230,240	6,216 New	6,216 $230,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.